Herbas VPB

Print
EN | LT
LT - Antikūnai prieš gliukokortikoidu indukuojamą naviko nekrozės faktoriaus receptorių (GITR) ir jų panaudojimas
EN - ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 35/00 (2006.01)
A61K 39/00 (2006.01)
C07K 16/28 (2006.01)
European patent
(11) Number of the document 3151921
(13) Kind of document T
(96) European patent application number 15742414.4
Date of filing the European patent application 2015-06-03
(97) Date of publication of the European application 2017-04-12
(45) Date of publication and mention of the grant of the patent 2019-08-28
(46) Date of publication of the claims translation 2019-12-10
PCT application
(86) Number PCT/US2015/033991
Date 2015-06-03
PCT application publication
(87) Number WO 2015/187835
Date 2015-12-10
Priority applications
(30) Number Date Country code
201462008945 P 2014-06-06 US
201462082980 P 2014-11-21 US
Inventors
(72)
WANG, Changyu, US
LONBERG, Nils, US
KORMAN, Alan J., US
SELBY, Mark J., US
SRINIVASAN, Mohan, US
HENNING, Karla, US
HAN, Michelle, Minhua, US
CHEN, Guodong, US
HUANG, Richard, US
CHAKRABORTY, Indrani, US
HUANG, Haichun, US
WONG, Susan, US
LI, Huiming, US
Grantee
(73) Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US
Attorney or representative
(74) Otilija KLIMAITIENĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Antikūnai prieš gliukokortikoidu indukuojamą naviko nekrozės faktoriaus receptorių (GITR) ir jų panaudojimas
  ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
Last renewal fee
Payment date Validity (years) Amount
2023-05-29 9 208.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2024-06-03